CD109
Basic information
Region (hg38): 6:73695785-73828316
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CD109 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 75 | 87 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 4 | 5 | |||
non coding | 2 | |||||
Total | 0 | 0 | 75 | 9 | 9 |
Variants in CD109
This is a list of pathogenic ClinVar variants found in the CD109 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-73696223-G-T | not specified | Uncertain significance (Jun 18, 2021) | ||
6-73696229-C-A | not specified | Uncertain significance (Nov 08, 2024) | ||
6-73696252-C-T | not specified | Uncertain significance (Oct 11, 2024) | ||
6-73696285-C-T | not specified | Uncertain significance (Jun 30, 2022) | ||
6-73697404-C-T | not specified | Uncertain significance (Jan 16, 2024) | ||
6-73697425-G-A | not specified | Uncertain significance (Dec 21, 2022) | ||
6-73697504-C-T | not specified | Uncertain significance (Nov 09, 2021) | ||
6-73697534-C-G | not specified | Uncertain significance (Jan 09, 2024) | ||
6-73730363-A-G | not specified | Uncertain significance (Aug 19, 2024) | ||
6-73730392-C-T | not specified | Uncertain significance (Jun 05, 2024) | ||
6-73730401-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
6-73730412-A-T | not specified | Uncertain significance (Jun 23, 2023) | ||
6-73730512-C-T | not specified | Uncertain significance (Sep 02, 2024) | ||
6-73730563-A-T | not specified | Uncertain significance (Feb 03, 2022) | ||
6-73730573-A-G | not specified | Uncertain significance (Oct 09, 2024) | ||
6-73736471-C-T | not specified | Uncertain significance (Apr 15, 2024) | ||
6-73736473-A-G | not specified | Uncertain significance (Jul 30, 2023) | ||
6-73736491-A-G | Benign (Nov 01, 2022) | |||
6-73756680-A-G | not specified | Uncertain significance (Mar 22, 2023) | ||
6-73758983-A-G | not specified | Uncertain significance (Mar 25, 2024) | ||
6-73758991-A-G | not specified | Uncertain significance (May 18, 2022) | ||
6-73758995-A-G | not specified | Uncertain significance (Nov 09, 2022) | ||
6-73759022-C-T | not specified | Uncertain significance (Feb 16, 2023) | ||
6-73762467-C-T | not specified | Uncertain significance (Aug 20, 2024) | ||
6-73762742-T-C | not specified | Uncertain significance (Mar 22, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CD109 | protein_coding | protein_coding | ENST00000287097 | 33 | 132533 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.27e-44 | 8.72e-7 | 125409 | 2 | 337 | 125748 | 0.00135 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.503 | 755 | 717 | 1.05 | 0.0000342 | 9426 |
Missense in Polyphen | 183 | 157.96 | 1.1585 | 2136 | ||
Synonymous | 0.459 | 253 | 262 | 0.964 | 0.0000130 | 2749 |
Loss of Function | 0.221 | 68 | 70.0 | 0.972 | 0.00000325 | 917 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00256 | 0.00256 |
Ashkenazi Jewish | 0.000899 | 0.000893 |
East Asian | 0.00188 | 0.00180 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.00102 | 0.00101 |
Middle Eastern | 0.00188 | 0.00180 |
South Asian | 0.00359 | 0.00344 |
Other | 0.000987 | 0.000978 |
dbNSFP
Source:
- Function
- FUNCTION: Modulates negatively TGFB1 signaling in keratinocytes. {ECO:0000269|PubMed:16754747}.;
- Pathway
- Post-translational modification: synthesis of GPI-anchored proteins;Post-translational protein modification;Metabolism of proteins;Platelet degranulation ;Response to elevated platelet cytosolic Ca2+;Platelet activation, signaling and aggregation;Hemostasis
(Consensus)
Recessive Scores
- pRec
- 0.124
Intolerance Scores
- loftool
- 1.00
- rvis_EVS
- 4.68
- rvis_percentile_EVS
- 99.78
Haploinsufficiency Scores
- pHI
- 0.269
- hipred
- N
- hipred_score
- 0.152
- ghis
- 0.391
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.356
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cd109
- Phenotype
- endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); immune system phenotype;
Gene ontology
- Biological process
- negative regulation of protein phosphorylation;hair follicle development;platelet degranulation;negative regulation of keratinocyte proliferation;negative regulation of endopeptidase activity;negative regulation of transforming growth factor beta receptor signaling pathway;regulation of keratinocyte differentiation;negative regulation of wound healing;osteoclast fusion
- Cellular component
- extracellular region;extracellular space;plasma membrane;cell surface;platelet alpha granule membrane;anchored component of membrane
- Molecular function
- serine-type endopeptidase inhibitor activity;transforming growth factor beta binding